Abnormal Deep Tendon Reflex
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse.
|
23419392 |
2013 |
Absent reflex
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse.
|
23419392 |
2013 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer Disease, Late Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer's Disease
|
0.340 |
AlteredExpression
|
disease |
LHGDN |
Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease.
|
11771745 |
2001 |
Alzheimer's Disease
|
0.340 |
Biomarker
|
disease |
BEFREE |
Accordingly, we have analysed polymorphisms in the genes that encode the alpha4 and beta2 subunits, CHRNA4 and CHRNB2 respectively, for genetic associations with late-onset AD.
|
15026168 |
2004 |
Alzheimer's Disease
|
0.340 |
Biomarker
|
disease |
BEFREE |
In addition to identifying the epsilon4 allele of APOE and related effects, we pinpointed over a dozen potential Alzheimer disease susceptibility genes (ACE, CHRNB2, CST3, ESR1, GAPDHS, IDE, MTHFR, NCSTN, PRNP, PSEN1, TF, TFAM and TNF) with statistically significant allelic summary odds ratios (ranging from 1.11-1.38 for risk alleles and 0.92-0.67 for protective alleles).
|
17192785 |
2007 |
Alzheimer's Disease
|
0.340 |
Biomarker
|
disease |
BEFREE |
A search for mutations of the genes coding for the most widely distributed nicotinic receptor subtype alpha4beta2 (CHRNA4/CHRNB2) has been performed in AD patients by screening the coding regions of both genes by single strand conformation analysis and heteroduplex analysis of fibroblast-derived genomic DNA.
|
10549797 |
1999 |
Alzheimer's Disease
|
0.340 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer's Disease
|
0.340 |
GeneticVariation
|
disease |
LHGDN |
Accordingly, we have analysed polymorphisms in the genes that encode the alpha4 and beta2 subunits, CHRNA4 and CHRNB2 respectively, for genetic associations with late-onset AD.
|
15026168 |
2004 |
Alzheimer's Disease, Focal Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Anxiety Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse.
|
23419392 |
2013 |
Anxiety neurosis (finding)
|
0.300 |
Biomarker
|
disease |
CTD_human |
The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse.
|
23419392 |
2013 |
Anxiety States, Neurotic
|
0.300 |
Biomarker
|
disease |
CTD_human |
The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse.
|
23419392 |
2013 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Control of breathing in newborn mice lacking the beta-2 nAChR subunit.
|
15450117 |
2004 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
|
21748252 |
2012 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Executive and social behaviors under nicotinic receptor regulation.
|
12876201 |
2003 |
Attention Deficit Disorder
|
0.500 |
Biomarker
|
disease |
MGD |
Retinal waves in mice lacking the beta2 subunit of the nicotinic acetylcholine receptor.
|
18757739 |
2008 |
Attention deficit hyperactivity disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.
|
21748252 |
2012 |
Autism Spectrum Disorders
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Autistic behavior
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A case of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) coexisting with pervasive developmental disorder harboring SCN1A mutation in addition to CHRNB2 mutation.
|
23032131 |
2012 |
Autistic Disorder
|
0.310 |
AlteredExpression
|
disease |
LHGDN |
Molecular analysis of nicotinic receptor expression in autism.
|
15046869 |
2004 |
Autistic Disorder
|
0.310 |
Biomarker
|
disease |
CTD_human |
Molecular analysis of nicotinic receptor expression in autism.
|
15046869 |
2004 |
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
|
0.500 |
Biomarker
|
disease |
BEFREE |
CHRNB2 is a new gene for idiopathic epilepsy, the second acetylcholine receptor subunit implicated in ADNFLE.
|
11104662 |
2001 |